Edition:
United States

Threshold Pharmaceuticals Inc (THLD.O)

THLD.O on Consolidated Issue listed on NASDAQ Capital Market

0.47USD
5 Dec 2016
Change (% chg)

$-0.01 (-1.80%)
Prev Close
$0.48
Open
$0.49
Day's High
$0.49
Day's Low
$0.45
Volume
301,062
Avg. Vol
2,848,475
52-wk High
$1.48
52-wk Low
$0.21

THLD.O

Chart for THLD.O

About

Threshold Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activat... (more)

Overall

Beta: 4.71
Market Cap(Mil.): $34.42
Shares Outstanding(Mil.): 71.56
Dividend: --
Yield (%): --

Financials

  THLD.O Industry Sector
P/E (TTM): 0.89 42.21 29.87
EPS (TTM): 0.54 -- --
ROI: 150.13 -1.09 14.95
ROE: -- -2.39 16.29

BRIEF-Threshold Pharmaceuticals qtrly loss per share $0.08

* Threshold pharmaceuticals reports third quarter financial results

Nov 07 2016

BRIEF-Threshold Pharmaceuticals Qtrly loss per share $0.08

* No revenue was recognized in Q3 ended September 30, 2016 compared to $3.7 million for same period of 2015

Nov 07 2016

BRIEF-Threshold Pharmaceuticals Q2 loss per share $0.10

* Threshold Pharmaceuticals reports second quarter financial results

Aug 01 2016

BRIEF-Threshold Pharmaceuticals says received preliminary comments from FDA

* On June 2, received preliminary comments from FDA relating to co' s request for a meeting Source text: (http://1.usa.gov/22ICDdw) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 06 2016

Competitors

Earnings vs. Estimates